Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.

Schlöder, Janine

Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. [electronic resource] - International journal of molecular sciences Jan 2017

Publication Type: Journal Article

1422-0067

10.3390/ijms18020271 doi


Adult
Animals
Dimethyl Fumarate--pharmacology
Down-Regulation--drug effects
Female
Graft vs Host Disease--immunology
Humans
Lymphocyte Activation--drug effects
Male
Mice
Middle Aged
Multiple Sclerosis--drug therapy
Receptors, Interleukin-6--metabolism
Spleen--pathology
T-Lymphocytes, Regulatory--drug effects
Young Adult